ATH 0.00% 0.5¢ alterity therapeutics limited

taurx, serious competition?

  1. 96 Posts.
    Hello anyone, i would be interested on views about TauRX.

    http://taurx.com/

    In early phase2 trials they noted fairly impressive results.

    Partly they claim their drug may stop progression in preclinical alzhiemers and has reduced progression by 80% in early patients (phase 2 trial).

    I am not sure if this companies technology has been discussed before, but they currently have phase 3 trials underway.

    Any thoughts?

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.6¢ 0.6¢ 0.5¢ $26.81K 4.868M

Buyers (Bids)

No. Vol. Price($)
45 42771258 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 20563308 22
View Market Depth
Last trade - 16.10pm 15/05/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 1735805
Last updated 13.27pm 15/05/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.